C-reactive protein (CRP) promotes malignant properties in pancreatic neuroendocrine neoplasms (scientific article published on 01 July 2019)

Significance of preoperative C-reactive protein as a parameter of the perioperative course and long-term prognosis in squamous cell carcinoma and adenocarcinoma of the oesophagus

Q33866407

Function of C-reactive protein

Q33942143

Human C-reactive protein: expression, structure, and function

Q34353024

C-reactive protein receptors on the human monocytic cell line U-937. Evidence for additional binding to Fc gamma RI.

Q34762515

STAT3 expression, molecular features, inflammation patterns, and prognosis in a database of 724 colorectal cancers

Q34796500

C-reactive protein as a marker of melanoma progression

Q35419890

Generation of C-reactive protein and complement components in atherosclerotic plaques

Q35746446

The major receptor for C-reactive protein on leukocytes is fcgamma receptor II.

Q36375211

STAT3 and STAT1 mediate IL-11-dependent and inflammation-associated gastric tumorigenesis in gp130 receptor mutant mice.

Q36570495

Stat3 activation in prostatic carcinomas.

Q53390466

The neuroendocrine phenotype, genomic profile and therapeutic sensitivity of GEPNET cell lines.

Q55260441

Hypoxia-inducible proto-oncogene Pim-1 is a prognostic marker in pancreatic ductal adenocarcinoma

Q57767618

Differential induction of interleukin-6 production by monocytes, endothelial cells and smooth muscle cells

Q68019930

C-reactive protein increases production of IL-1 alpha, IL-1 beta, and TNF-alpha, and expression of mRNA by human alveolar macrophages

Q70682279

Expression of C-reactive protein by alveolar macrophages

Q71120590

Loss of pentameric symmetry of C-reactive protein is associated with delayed apoptosis of human neutrophils

Q74666968

Prognostic impact of postoperative C-reactive protein level in patients with metastatic renal cell carcinoma undergoing cytoreductive nephrectomy

Q81446596

STAT 3 activation in head and neck squamous cell carcinomas is controlled by the EGFR

Q81451048

Preoperative elevation of serum C-reactive protein as an independent prognostic indicator for gastric cancer

Q83694828

Clinical significance of pretreatment serum C-reactive protein level in soft tissue sarcoma

Q84563145

[Mechanism of C-reactive protein on proliferation of multiple myeloma U266 cells]

Q84747875

Prevailing role of contact guidance in intrastromal T-cell trapping in human pancreatic cancer

Q87748672

C-reactive protein induces M-CSF release and macrophage proliferation

Q37073901

Activation of Stat3 by heregulin/ErbB-2 through the co-option of progesterone receptor signaling drives breast cancer growth

Q37099924

One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States

Q37195528

Validation of C-reactive protein levels as a prognostic indicator for survival in a large cohort of pancreatic cancer patients.

Q37459643

The diversity and commonalities of gastroenteropancreatic neuroendocrine tumors

Q37832970

The epidemiology of gastroenteropancreatic neuroendocrine tumors.

Q37846915

Cancer-related inflammation: common themes and therapeutic opportunities

Q37972525

The esophagitis to adenocarcinoma sequence; the role of inflammation

Q38133153

New insights into the role of chronic inflammation and cytokines in the etiopathogenesis of gastroenteropancreatic neuroendocrine tumors

Q38200839

The role of inflammation in sarcoma

Q38211082

Interleukin-6: a villain in the drama of pancreatic cancer development and progression

Q38237583

Inflammatory lipid sphingosine-1-phosphate upregulates C-reactive protein via C/EBPβ and potentiates breast cancer progression

Q38447666

Differential expression and tumorigenic function of neurotensin receptor 1 in neuroendocrine tumor cells

Q38841614

Whole-exome characterization of pancreatic neuroendocrine tumor cell lines BON-1 and QGP-1.

Q38917473

A mechanistic role for the chromatin modulator, NAP1L1, in pancreatic neuroendocrine neoplasm proliferation and metastases

Q38970716

Interleukin-6 drives melanoma cell motility through p38α-MAPK-dependent up-regulation of WNT5A expression

Q38982133

DNA damage induces the IL-6/STAT3 signaling pathway, which has anti-senescence and growth-promoting functions in human tumors

Q39361385

The clinical implications and biologic relevance of neurofilament expression in gastroenteropancreatic neuroendocrine neoplasms

Q39459743

High-sensitivity C-reactive protein (hs-CRP) as a biomarker for trastuzumab-induced cardiotoxicity in HER2-positive early-stage breast cancer: a pilot study

Q39632536

STAT3 and MAPK signaling maintain overexpression of heat shock proteins 90alpha and beta in multiple myeloma cells, which critically contribute to tumor-cell survival

Q40227240

Autocrine IL-6-induced Stat3 activation contributes to the pathogenesis of lung adenocarcinoma and malignant pleural effusion.

Q40308418

C-Reactive Protein as a New Prognostic Factor for Survival in Patients With Pancreatic Neuroendocrine Neoplasia

Q41041360

Interleukin-6-dependent and -independent regulation of the human C-reactive protein gene

Q41853993

Activation of Stat3 in renal tumors.

Q42013920

Binding and internalization of C-reactive protein by Fcgamma receptors on human aortic endothelial cells mediates biological effects

Q46463135

C-reactive protein can influence the proliferation, apoptosis, and monocyte chemotactic protein-1 production of human umbilical vein endothelial cells

Q48983190

Human neurons generate C-reactive protein and amyloid P: upregulation in Alzheimer's disease

Q49124233

P275

Creative Commons Attribution-NonCommercial 4.0 International

copyrighted

describes a project that uses

ImageJ